Özet:

The aim of the work. To analyze the range of drugs for the treatment of obstructive pulmonary diseases (code ATS R03) in the modern pharmaceutical market of Ukraine and determine the feasibility of new drugs development on the basis of the marketing research. Materials and Methods. The work is done using statistical, logical and graphical methods. Results and Discussion. As a result of marketing research and analysis of a range of drugs at ATC code R03, which were registered on the territory of Ukraine are the following: most of the medicines presented in the form of a powder for inhalations; the prevailing share of the range (76.1 %) in the investigated drugs are monotherapies; the proportion of the range of products manufactured in the pharmaceutical enterprises of Ukraine is 21 %; the greatest number of drugs made by domestic company is the producer of "Yuria-Pharm" and LLC "Multispray". Conclusion. Analysis of the pharmaceutical market in Ukraine showed that the share of domestic drugs is small (21 %), and the range of dosage forms needs expansion. Particularly noteworthy are the least numerous forms: syrups, capsules, suspensions, granules, inhalants, solutions for injection and infusions.

Anahtar Kelimeler: